Pfizer Share Price
4586.30-57.40 (-1.24%)
-11.36% past 1 Year
Pfizer is engaged in manufacturing, marketing, distribution and trading of pharmaceutical products. The company has its own manufacturing facility. The company also has various independent contract / third party manufacturers
Corporate filings & documents
Announcements
Newspaper Advertisement - Special Window for Re- lodgement of Transfer and Dematerialisation of Physical Securities.
1 month agoNewspaper Advertisement - Special Window for Re- lodgement of Transfer and Dematerialisation of Physical Securities.
1 month agoPursuant to Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we submit herewith the consolidated Scrutinizers Report of the votes cast through remote e-voting and electronic polling process conducted during the 75th Annual General Meeting of the Company held on Tuesday July 28 2026 at 3.00 p.m. IST.
1 month agoPursuant to Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we submit herewith the consolidated Scrutinizers Report of the votes cast through remote e-voting and electronic polling process conducted during the 75th Annual General Meeting of the Company held on Tuesday July 28 2026 at 3.00 p.m. IST.
1 month agoPursuant to Regulation 30 of SEBI LODR Regulations 2015 please find enclosed proceedings of the 75th Annual General Meeting of the Company held on July 28 2026.
1 month agoPursuant to Regulation 30 of SEBI LODR Regulations 2015 please find enclosed proceedings of the 75th Annual General Meeting of the Company held on July 28 2026.
1 month agoPursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the Unaudited Financial Results of the Company for the quarter ended June 30 2026 which were approved by the Board of Directors of the Company at their Meeting held today i.e. July 28 2026 that commenced at11.30 a.m. and concluded at 1.35 p.m.
1 month agoPursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the Unaudited Financial Results of the Company for the quarter ended June 30 2026 which were approved by the Board of Directors of the Company at their Meeting held today i.e. July 28 2026 that commenced at11.30 a.m. and concluded at 1.35 p.m.
1 month agoIntimation of Resignation of Mr. Amit Agarwal Executive Director -Finance & Chief Financial Officer
1 month agoIntimation of Resignation of Mr. Amit Agarwal Executive Director -Finance & Chief Financial Officer
1 month agoPfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday July 28 2026 inter alia to consider approve and take on record the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month agoPfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday July 28 2026 inter alia to consider approve and take on record the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month agoResponse to clarification sought with reference to news item appearing in The Hindu BusinessLine
1 month agoResponse to clarification sought with reference to news item appearing in The Hindu BusinessLine
1 month agoThe Exchange has sought clarification from Pfizer Ltd on July 17 2026 with reference to news appeared in https://www.thehindubusinessline.com/ dated July 17 2026 quoting "Pfizer suspends Premarin vaginal cream in India raising concerns over menopause care" <BR><BR>The reply is awaited.
1 month agoThe Exchange has sought clarification from Pfizer Ltd on July 17 2026 with reference to news appeared in https://www.thehindubusinessline.com/ dated July 17 2026 quoting "Pfizer suspends Premarin vaginal cream in India raising concerns over menopause care" <BR><BR>The reply is awaited.
1 month agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026
1 month agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026
1 month agoAttached herewith is the letter sent to shareholders providing the weblink to access the Annual Report.
1 month agoAttached herewith is the letter sent to shareholders providing the weblink to access the Annual Report.
1 month agoNewspaper Advertisement - Notice of the 75th Annual General Meeting
1 month agoNewspaper Advertisement - Notice of the 75th Annual General Meeting
1 month agoNotice of the 75th AGM of the Company scheduled to be held on July 28 2026.
1 month agoNotice of the 75th AGM of the Company scheduled to be held on July 28 2026.
1 month agoAnnual Report for Financial Year ended 2025- 26
1 month agoAnnual Report for Financial Year ended 2025- 26
1 month agoThis is to inform you that for the purpose of declaration of Unaudited Financial Results of the Company the trading window shall remain closed from Tuesday June 30 2026 (close of business) till 48 hours after financial results are made public.
2 months agoThis is to inform you that for the purpose of declaration of Unaudited Financial Results of the Company the trading window shall remain closed from Tuesday June 30 2026 (close of business) till 48 hours after financial results are made public.
2 months agoPlease find enclosed Newspaper Advertisement for transfer of unclaimed Dividend and Shares to IEPF.
3 months agoSpecial Window for Re-lodgement of Transfer and Dematerialisation of Physical Securities.
3 months agoSpecial Window for Re-lodgement of Transfer and Dematerialisation of Physical Securities.
3 months agoWe submit herewith the Annual Secretarial Compliance Report for the financial year ended March 31 2026 issued by Parikh & Associates Practicing Company Secretaries.
3 months agoAppointment of Cost Auditors
3 months agoThe Board of Directors at their meeting held today approved convening of 75th Annual General Meeting of the Company on July 28 2026.
3 months agoThe Board of Directors at their meeting held today approved convening of 75th Annual General Meeting of the Company on July 28 2026.
3 months agoThe Company has fixed Friday July 17 2026 as the record date for determining entitlement of Members to the final dividend for the financial year ended March 31 2026.
3 months agoThe Company has fixed Friday July 17 2026 as the record date for determining entitlement of Members to the final dividend for the financial year ended March 31 2026.
3 months agoThe Board of Directors has recommended a final dividend of Rs. 75/- per equity share of Rs. 10/- each (750%) for the financial year ended March 31 2026.
3 months agoThe Board of Directors has recommended a final dividend of Rs. 75/- per equity share of Rs. 10/- each (750%) for the financial year ended March 31 2026.
3 months agoPursuant to Regulation 33 of SEBI LODR 2015 we submit herewith Audited Financial Results for the financial year ended March 31 2026.
3 months agoPursuant to Regulation 33 of SEBI LODR 2015 we submit herewith Audited Financial Results for the financial year ended March 31 2026.
3 months agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you the outcome of meeting of Board of Directors of the Company held today i.e. May 12 2026.
3 months agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you the outcome of meeting of Board of Directors of the Company held today i.e. May 12 2026.
3 months agoPfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 12 2026 inter alia to consider approve and take on record the financial results of the Company for the quarter and year ended March 31 2026 and to consider recommendation of dividend if any for the financial year ended March 31 2026.
4 months agoPursuant to Regulation 30 of SEBI LODR Regulations 2015 we hereby inform the receipt of an Assessment Order and tax demand issued by Income Tax Department - Assessment Unit
4 months agoPursuant to Regulation 30 of SEBI LODR Regulations 2015 we hereby inform the receipt of an Assessment Order and tax demand issued by Income Tax Department - Assessment Unit
4 months agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026
4 months agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026
4 months agoNewspaper Advertisement - Special Window for Re - lodgement of transfer and Dematerialization of Physical Securities.
4 months agoIntimation regarding change in Senior Management Personnel of the Company.
5 months agoConcalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2026-07-17
Dividend
75.0
2025-07-09
Dividend
35.0
2025-07-09
Dividend
130.0
2024-08-21
Dividend
35.0
2023-08-11
Dividend
35.0
2022-08-18
Dividend
35.0
2021-08-11
Dividend
35.0
2020-08-27
Dividend
10.0
2020-05-06
Dividend
320.0
2018-08-29
Dividend
20.0
2017-08-22
Dividend
20.0
2016-06-27
Dividend
15.0
2015-07-03
Dividend
12.5
2013-12-05
Dividend
360.0
2013-08-28
Dividend
32.5
2012-07-24
Dividend
12.5
2011-07-08
Dividend
4.0
2011-01-20
Dividend
12.5
Company details
Registered office
The Capital, 1802/1901, Plot No. C-70, G Block Bandra Kurla Complex Bandra (East) Mumbai Maharashtra PIN: 400051 Tel No: 022 6693 2000 Fax No: 022 2654 0274 Email: [email protected] Internet: www.pfizerltd.co.in
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Prajeet Nair, Director- Corporate Services & Company Secretary, Compliance Officer
Pradip Shah, Chairman
Meenakshi Nevatia, Managing Director
L Krishnakumar, Non Executive Independent Director
Amit Agarwal, Whole Time Director - Finance & Chief Financial Officer
Meena Ganesh, Non Executive Independent Director
P Rengan, Whole Time Director - Plant Operations
Sonia Singh, Non Executive Independent Director
Details
BSE 500680
NSE PFIZER
ISIN INE182A01018